09.01.2013 Views

2 - TI Pharma

2 - TI Pharma

2 - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 5 Glucocorticoids, islet-cell function & ANS<br />

14. Hansen KB, Vilsboll T, Bagger jI, Holst jj, Knop FK. Increased postprandial GIP and glucagon<br />

responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical<br />

inactivity, and high-calorie diet in healthy subjects. j Clin Endocrinol Metab. 2011;96(2):447-53.<br />

15. Wise JK, Hendler R, Felig P. Influence of glucocorticoids on glucagon secretion and plasma amino<br />

acid concentrations in man. j Clin Invest. 1973;52(11):2774-82.<br />

16. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of<br />

pancreatic beta-cell function. Endocr Rev. 2001;22(5):565-604.<br />

17. Campfield LA, Smith FJ. Neural control of insulin secretion: interaction of norepinephrine and<br />

acetylcholine. Am j Physiol. 1983;244(5):R629-34.<br />

18. Ahren B. Autonomic regulation of islet hormone secretion--implications for health and disease.<br />

Diabetologia. 2000;43(4):393-410.<br />

19. DeFronzo RA, Tobin jD, Andres R. Glucose clamp technique: a method for quantifying insulin<br />

secretion and resistance. Am j Physiol. 1979;237(3):E214-23.<br />

20. Imholz BP, Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience with finger arterial<br />

pressure monitoring: assessment of the technology. Cardiovasc Res. 1998;38(3):605-16.<br />

21. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use.<br />

Task Force of the European Society of Cardiology and the North American Society of Pacing and<br />

Electrophysiology. Eur Heart j. 1996;17(3):354-81.<br />

22. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst jj. Tissue and plasma concentrations of amidated<br />

and glycine-extended glucagon-like peptide I in humans. Diabetes. 1994;43(4):535-9.<br />

23. Deacon CF, Nauck MA, Meier j, Hucking K, Holst jj. Degradation of endogenous and exogenous gastric<br />

inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for<br />

the intact peptide. j Clin Endocrinol Metab. 2000;85(10):3575-81.<br />

24. Mari A, Tura A, Gastaldelli A, Ferrannini E. Assessing insulin secretion by modeling in multiple-meal<br />

tests: role of potentiation. Diabetes. 2002;51 Suppl 1:S221-6.<br />

25. Henquin jC. Regulation of insulin secretion: a matter of phase control and amplitude modulation.<br />

Diabetologia. 2009;52(5):739-51.<br />

26. Bonuccelli S, Muscelli E, Gastaldelli A, Barsotti E, Astiarraga BD, Holst jj, Mari A, Ferrannini E.<br />

Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms. Am<br />

j Physiol Endocrinol Metab. 2009;297(2):E532-7.<br />

27. Taborsky Gj, jr., Smith PH, Halter jB, Porte D, jr. Glucose infusion potentiates the acute insulin response<br />

to nonglucose stimuli during the infusion of somatostatin. Endocrinology. 1979;105(5):1215-20.<br />

28. Atef N, Laury MC, N’Guyen JM, Mokhtar N, Ktorza A, Penicaud L. Increased pancreatic islet blood<br />

flow in 48-hour glucose-infused rats: involvement of central and autonomic nervous systems.<br />

Endocrinology. 1997;138(5):1836-40.<br />

108

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!